This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Arctic Pharma as. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Bora Sieng: Innovator in LDHA Activity Inhibition
Introduction
Bora Sieng is a notable inventor based in Oslo, Norway. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that inhibit lactate dehydrogenase A (LDHA). His work is crucial in the fight against diseases such as cancer.
Latest Patents
Bora Sieng holds a patent for LDHA activity inhibitors. The invention provides compounds of formula (I), including stereoisomers, tautomers, pharmaceutically acceptable salts, and prodrugs. These compounds are designed for the treatment or prevention of diseases mediated by the activation of LDHA, making them valuable in cancer therapy. He has 1 patent to his name.
Career Highlights
Bora Sieng is currently employed at Arctic Pharma AS, where he continues to innovate in the pharmaceutical sector. His work focuses on developing new therapeutic options that can significantly impact patient care.
Collaborations
Bora collaborates with talented professionals such as Jo Klaveness and Steffi Lundvall. Their combined expertise enhances the research and development efforts at Arctic Pharma AS.
Conclusion
Bora Sieng is a dedicated inventor whose work on LDHA activity inhibitors represents a significant advancement in cancer treatment. His contributions to the field are noteworthy and continue to inspire innovation in pharmaceuticals.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile